Lmr Partners LLP Cerevel Therapeutics Holdings, Inc. Put Options Transaction History

Lmr Partners LLP

  • $10.9 Billion
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$38.96 - $42.75 $21.5 Million - $23.5 Million
550,600 Added 219.36%
801,600 $32.8 Million
Q1 2024

May 15, 2024
SELL
$40.88 - $43.27 $2.08 Million - $2.2 Million
-50,900 Reduced 16.86%
251,000 $10.6 Million
Q4 2023

Feb 14, 2024
BUY
$20.27 - $42.44 $6.12 Million - $12.8 Million
301,900 New
301,900 $12.8 Million

Others Institutions Holding CERE

# of Institutions
8
Shares Held
5.01M
Call Options Held
3.3K
Put Options Held
0
View Full List

About Cerevel Therapeutics Holdings, Inc.

CERE Quotes by TradingView
  • Ticker CERE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 155,752,000
  • Description
  • Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...
More about CERE
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email